RVLP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 okt 2023 @ 22:00):

Stats
Dagens volum	63.96M
Gjennomsnittsvolum	24.42M
Markedsverdi	3.14M
EPS	$0 ( 2024-03-18 )
Neste inntjeningsdato	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0397
ATR14	$0.0230 (500.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-19	Harsaul Foundation	Sell	9 363 760	Ordinary Shares
2023-10-20	Harsaul Foundation	Sell	4 758 899	Ordinary Shares
2023-10-19	Altchem Ltd	Sell	9 363 760	Ordinary Shares
2023-10-20	Altchem Ltd	Sell	4 758 899	Ordinary Shares
2023-10-18	Harsaul Foundation	Sell	3 421 537	Ordinary Shares

INSIDER POWER
-78.51
Last 95 transactions
Buy: 43 304 967 \| Sell: 77 056 281

Volum Korrelasjon

Lang: -0.31 (neutral)

Kort: -0.42 (neutral)

Signal:(32.959) Neutral

RVL Pharmaceuticals plc Korrelasjon

10 Mest positive korrelasjoner
CSSEP	0.969
KBNT	0.967
AGFY	0.965
IDBA	0.96
CSSEN	0.959
IRBT	0.956
HGEN	0.953
GOVX	0.947
SINT	0.945
REVB	0.945

10 Mest negative korrelasjoner
ATVI	-0.958
AMYT	-0.956
DVCR	-0.954
TIOAU	-0.953
AVEO	-0.95
NVCN	-0.95
FLXS	-0.949
INBK	-0.948
APXI	-0.947
STAY	-0.943

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

RVL Pharmaceuticals plc Korrelasjon - Valuta/Råvare

-0.62
( weak negative )

-0.75
( moderate negative )

0.00
( neutral )

-0.50
( neutral )

-0.30
( neutral )

0.63
( weak )

RVL Pharmaceuticals plc Økonomi

Annual	2022
Omsetning:	$49.72M
Bruttogevinst:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2022
Omsetning:	$49.72M
Bruttogevinst:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2021
Omsetning:	$17.50M
Bruttogevinst:	$13.88M (79.33 %)
EPS:	$-0.960

FY	2020
Omsetning:	$177.88M
Bruttogevinst:	$103.40M (58.13 %)
EPS:	$-1.310

Financial Reports:

No articles found.

RVL Pharmaceuticals plc

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Sanntidsoppdatering for RVL Pharmaceuticals plc [RVLP]

Upcoming Earnings Alert